mitomycin C-based hyperthermic intraperitoneal chemotherapy
JHuang
Phase 3 other active
Quick answer
mitomycin C-based hyperthermic intraperitoneal chemotherapy for Hepatocellular Carcinoma is a Phase 3 program (other) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Hepatocellular Carcinoma
- Phase
- Phase 3
- Modality
- other
- Status
- active